Literature DB >> 773497

Management of early cancer of the breast. Report on an international multicentre trial supported by the Cancer Research Campaign.

.   

Abstract

In the largest controlled clinical study so far undertaken on the management of early cancer of the breast in women the results of a radical regimen (simple mastectomy and radiotherapy) were compared with those of a conservative policy (simple mastectomy alone). The study included enough patients (2268) to ensure that small but significant differences between the two treatments would emerge. With a five-year follow-up there was no evidence that routine postoperative radiotherapy was harmful or that it conferred further benefit as regards survival or distant recurrence. Radiotherapy did, however, reduce the incidence of local recurrence. Neither form of treatment can counter occult disease far from the breast that is present at the time of initial treatment, which probably accounts for the high death rate from breast cancer, but the results of the study would support the view that conservative primary treatment and subsequent adjuvant chemotherapy may be the treatment of choice in future.

Entities:  

Mesh:

Year:  1976        PMID: 773497      PMCID: PMC1639888          DOI: 10.1136/bmj.1.6017.1035

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Cancer Research Campaign breast study.

Authors:  J G Murray
Journal:  Br J Surg       Date:  1974-10       Impact factor: 6.939

2.  Simple versus radical mastectomy. Preliminary report of the Cardiff breast trial.

Authors:  M M Roberts; L H Blumgart; M Davies; J M Henk; A P Forrest; H Campbell; E N Gleave; P B Kunkler; R Shields; M Hulbert; C W Jamieson; R A Sellwood
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

3.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

4.  Cellular immune competence of breast cancer patients receiving radiotherapy.

Authors:  A B Cosimi; F H Brunstetter; W T Kemmerer; B N Miller
Journal:  Arch Surg       Date:  1973-10

5.  The number of patients required in a clinical trial.

Authors:  J W Boag; J L Haybittle; J F Fowler; E W Emery
Journal:  Br J Radiol       Date:  1971-02       Impact factor: 3.039

6.  Immunological changes after radiotherapy for mammary carcinoma.

Authors:  J Stjernswärd
Journal:  Ann Inst Pasteur (Paris)       Date:  1972-04

7.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

8.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

9.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybrittle
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

10.  Organization of clinical trial on national scale: management of early cancer of the breast.

Authors:  M Baum; M H Edwards; C J Magarey
Journal:  Br Med J       Date:  1972-11-25
View more
  6 in total

1.  Cancer research campaign study of the management of "early" breast cancer.

Authors:  J G Murray; J MacIntyre; J S Simpson; A M McDonald
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  Controlled trials in the treatment of "early" breast cancer: a review of published results.

Authors:  H J Stewart
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

3.  The role of radiotherapy following total mastectomy for patients with early breast cancer.

Authors:  D A Berstock; J Houghton; J Haybittle; M Baum
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Five decades of progress in surgical oncology: Breast.

Authors:  Stephanie Downs-Canner; Hiram S Cody
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

Review 5.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

6.  Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience.

Authors:  E Velez-Garcia; M Moore; C L Vogel; V Marcial; A Ketcham; A Bartolucci; C Liu; R Smalley
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.